Résultats de la recherche - Hartwig Huland
- Résultat(s) 1 - 20 résultats de 31
- Aller à la page suivante
-
1
-
2
-
3
Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomes par Sue Evans, Jeremy Millar, Caroline M. Moore, John D. Lewis, Hartwig Huland, Fanny Sampurno, Sarah E. Connor, Paul Villanti, Mark S. Litwin
Publié 2017Artigo -
4
Postoperative complications of contemporary open and robot‐assisted laparoscopic radical prostatectomy using standardised reporting systems par Raisa S. Pompe, Burkhard Beyer, Alexander Haese, Felix Preißer, Uwe Michl, Thomas Steuber, Markus Graefen, Hartwig Huland, Pierre I. Karakiewicz, Derya Tilki
Publié 2018Artigo -
5
Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality par Derya Tilki, Ming‐Hui Chen, Jing Wu, Hartwig Huland, Markus Graefen, Michelle H. Braccioforte, Brian J. Moran, Anthony V. D’Amico
Publié 2018Artigo -
6
Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Angiogenesis and Invasion of Human Urinary Bladder Cancer par Leticia Oliveira‐Ferrer, Derya Tilki, Gudrun Ziegeler, Jessica Hauschild, Sonja Loges, Ster Irmak, Ergin Kilic, Hartwig Huland, Martin G. Friedrich, Süleyman Ergün
Publié 2004Artigo -
7
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men par Felix K.‐H. Chun, Alexander Haese, Sascha Ahyai, Jochen Walz, Nazareno Suardi, Umberto Capitanio, Markus Graefen, Andreas Erbersdobler, Hartwig Huland, Pierre I. Karakiewicz
Publié 2008Artigo -
8
Currently used criteria for active surveillance in men with low‐risk prostate cancer par Nazareno Suardi, Umberto Capitanio, Felix K.‐H. Chun, Markus Graefen, Paul Perrotte, Thorsten Schlomm, Alexander Haese, Hartwig Huland, Andreas Erbersdobler, Francesco Montorsi, Pierre I. Karakiewicz
Publié 2008Artigo -
9
DEVELOPMENT AND VALIDATION OF A NOMOGRAM PREDICTING THE OUTCOME OF PROSTATE BIOPSY BASED ON PATIENT AGE, DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE SPECIFIC ANTIGEN par Pierre I. Karakiewicz, Serge Benayoun, Michael W. Kattan, Paul Perrotte, Luc Valiquette, Peter T. Scardino, Ilias Cagiannos, Hans Heinzer, Simon Tanguay, Armen Aprikian, Hartwig Huland, Markus Graefen
Publié 2005Artigo -
10
Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death par Derya Tilki, Ming‐Hui Chen, Jing Wu, Hartwig Huland, Markus Graefen, Osama Mohamad, Janet E. Cowan, Felix Y. Feng, Peter R. Carroll, Anthony V. D’Amico
Publié 2023Artigo -
11
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria par Philipp Mandel, Thomas Steuber, Sascha Ahyai, Maximilian C. Kriegmair, Jonas Schiffmann, Katharina Böehm, Hans Heinzer, Uwe Michl, Thorsten Schlomm, Alexander Haese, Hartwig Huland, Markus Graefen, Derya Tilki
Publié 2015Artigo -
12
Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review par Christopher J.D. Wallis, Adam Glaser, Jim C. Hu, Hartwig Huland, Nathan Lawrentschuk, Daniel Moon, Declan G. Murphy, Paul L. Nguyen, Matthew J. Resnick, Robert K. Nam
Publié 2017Revisão -
13
Clinical Significance of Epidermal Growth Factor Receptor Protein Overexpression and Gene Copy Number Gains in Prostate Cancer par Thorsten Schlomm, Patrick Kirstein, Liv Iwers, Birte Daniel, Thomas Steuber, Jochen Walz, Felix Chun, Alexander Haese, Jens Köllermann, Markus Graefen, Hartwig Huland, Guido Sauter, Ronald Simon, Andreas Erbersdobler
Publié 2007Artigo -
14
CXCR3 and CCR5 Positive T-Cell Recruitment in Acute Human Renal Allograft Rejection par Ulf Panzer, Rüdiger Reinking, Oliver M. Steinmetz, Gunther Zahner, Ulrike Sudbeck, Susanne Fehr, Benjamin Pfalzer, André Schneider, Friedrich Thaiss, Matthias Mack, S. Conrad, Hartwig Huland, Udo Helmchen, Rolf A.K. Stahl
Publié 2004Artigo -
15
<i>CHD1</i> Is a 5q21 Tumor Suppressor Required for <i>ERG</i> Rearrangement in Prostate Cancer par Lia Burkhardt, Sarah Fuchs, Antje Krohn, Sawinee Masser, Malte Mäder, Martina Kluth, Frederik Bachmann, Hartwig Huland, Thomas Steuber, Markus Graefen, Thorsten Schlomm, Sarah Minner, Guido Sauter, Hüseyin Sirma, Ronald Simon
Publié 2013Artigo -
16
High mitochondria content is associated with prostate cancer disease progression par Katharina Grupp, Karolina Jedrzejewska, Maria Christina Tsourlakis, Christina Koop, Waldemar Wilczak, Meike Adam, Alexander Quaas, Guido Sauter, Ronald Simon, Jakob R. Izbicki, Markus Graefen, Hartwig Huland, Thorsten Schlomm, Sarah Minner, Stefan Steurer
Publié 2013Artigo -
17
βIII-Tubulin Overexpression Is an Independent Predictor of Prostate Cancer Progression Tightly Linked to ERG Fusion Status and PTEN Deletion par Maria Tsourlakis, Philipp Weigand, Katharina Grupp, Martina Kluth, Stefan Steurer, Thorsten Schlomm, Markus Graefen, Hartwig Huland, Georg Salomon, Thomas Steuber, Waldemar Wilczak, Hüseyin Sirma, Ronald Simon, Guido Sauter, Sarah Minner, Alexander Quaas
Publié 2014Artigo -
18
Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer par Christoph Burdelski, Viktor Reiswich, Claudia Hube‐Magg, Martina Kluth, Sarah Minner, Christina Koop, Markus Graefen, Hans Heinzer, Maria Christina Tsourlakis, Corinna Wittmer, Hartwig Huland, Ronald Simon, Thorsten Schlomm, Guido Sauter, Stefan Steurer
Publié 2015Artigo -
19
High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer par Sarah Minner, Corinna Wittmer, Markus Graefen, Georg Salomon, Thomas Steuber, Alexander Haese, Hartwig Huland, Carsten Bokemeyer, Emre F. Yekebas, Judith Dierlamm, Stefan Balabanov, Ergin Kilic, Waldemar Wilczak, Ronald Simon, Guido Sauter, Thorsten Schlomm
Publié 2010Artigo -
20
Clinical significance of p53 alterations in surgically treated prostate cancers par Thorsten Schlomm, Liv Iwers, Patrick Kirstein, Birte Jessen, Jens Köllermann, Sarah Minner, Annika Passow-Drolet, Martina Mirlacher, Karin Milde‐Langosch, Markus Graefen, Alexander Haese, Thomas Steuber, Ronald Simon, Hartwig Huland, Guido Sauter, Andreas Erbersdobler
Publié 2008Artigo
Outils de recherche:
Sujets similaires
Cancer
Medicine
Internal medicine
Prostate cancer
Oncology
Prostate
Biology
Cancer research
Prostatectomy
Pathology
Genetics
Gene
Urology
Immunohistochemistry
Apoptosis
PI3K/AKT/mTOR pathway
PTEN
Androgen deprivation therapy
Gynecology
Tissue microarray
Biochemical recurrence
Cohort
Disease
Erg
PCA3
Prostate-specific antigen
Radiation therapy
Coronavirus disease 2019 (COVID-19)
Gene expression
Immunology